Cargando…

Correction: Differential response to donepezil in MRI subtypes of mild cognitive impairment

Detalles Bibliográficos
Autores principales:	Diaz‑Galvan, Patricia, Lorenzon, Giulia, Mohanty, Rosaleena, Mårtensson, Gustav, Cavedo, Enrica, Lista, Simone, Vergallo, Andrea, Kantarci, Kejal, Hampel, Harald, Dubois, Bruno, Grothe, Michel J., Ferreira, Daniel, Westman, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576352/ https://www.ncbi.nlm.nih.gov/pubmed/37838742 http://dx.doi.org/10.1186/s13195-023-01320-8

Ejemplares similares

Differential response to donepezil in MRI subtypes of mild cognitive impairment
por: Diaz-Galvan, Patricia, et al.
Publicado: (2023)

Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer’s disease
por: Cavedo, Enrica, et al.
Publicado: (2017)

The hippocampal sparing subtype of Alzheimer’s disease assessed in neuropathology and in vivo tau positron emission tomography: a systematic review
por: Ferreira, Daniel, et al.
Publicado: (2022)

Comparison of subtyping methods for neuroimaging studies in Alzheimer’s disease: a call for harmonization
por: Mohanty, Rosaleena, et al.
Publicado: (2020)

Aptamarker prediction of brain amyloid-β status in cognitively normal individuals at risk for Alzheimer’s disease
por: Penner, Gregory, et al.
Publicado: (2021)

Basal Forebrain Volume, but Not Hippocampal Volume, Is a Predictor of Global Cognitive Decline in Patients With Alzheimer's Disease Treated With Cholinesterase Inhibitors
por: Teipel, Stefan J., et al.
Publicado: (2018)

Neuropathologic Features of Antemortem Atrophy-Based Subtypes of Alzheimer Disease
por: Mohanty, Rosaleena, et al.
Publicado: (2022)

Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study
por: Baldacci, Filippo, et al.
Publicado: (2020)

MRI data-driven clustering reveals different subtypes of Dementia with Lewy bodies
por: Inguanzo, Anna, et al.
Publicado: (2023)

No association of cortical amyloid load and EEG connectivity in older people with subjective memory complaints
por: Teipel, Stefan, et al.
Publicado: (2017)

Partial Volume Correction Increases the Sensitivity of 18F-Florbetapir-Positron Emission Tomography for the Detection of Early Stage Amyloidosis
por: Teipel, Stefan J., et al.
Publicado: (2021)

Donepezil for mild cognitive impairment in Parkinson’s disease
por: Baik, Kyoungwon, et al.
Publicado: (2021)

Biomarker-Drug and Liquid Biopsy Co-development for Disease Staging and Targeted Therapy: Cornerstones for Alzheimer’s Precision Medicine and Pharmacology
por: Hampel, Harald, et al.
Publicado: (2019)

Biomarkers for Alzheimer’s Disease (AD) and the Application of Precision Medicine
por: Lukiw, Walter J., et al.
Publicado: (2020)

Associations between different tau-PET patterns and longitudinal atrophy in the Alzheimer’s disease continuum: biological and methodological perspectives from disease heterogeneity
por: Mohanty, Rosaleena, et al.
Publicado: (2023)

Correction: Associations between different tau‑PET patterns and longitudinal atrophy in the Alzheimer’s disease continuum: biological and methodological perspectives from disease heterogeneity
por: Mohanty, Rosaleena, et al.
Publicado: (2023)

The Sars-Cov-2 Pandemic and the Brave New Digital World of Environmental Enrichment to Prevent Brain Aging and Cognitive Decline
por: Hampel, Harald, et al.
Publicado: (2020)

Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study
por: Sakr, Fatemah A., et al.
Publicado: (2019)

Correction: Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study
por: Sakr, Fatemah A., et al.
Publicado: (2022)

microRNA-Based Biomarkers in Alzheimer’s Disease (AD)
por: Zhao, Yuhai, et al.
Publicado: (2020)

MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints
por: Vergallo, Andrea, et al.
Publicado: (2021)

Mild Cognitive Impairment and Donepezil Impact Mitochondrial Respiratory Capacity in Skeletal Muscle
por: Morris, Jill K, et al.
Publicado: (2021)

Fractional Anisotropy of the Fornix and Hippocampal Atrophy in Alzheimer’s Disease
por: Kantarci, Kejal
Publicado: (2014)

2021 marks a new era for Alzheimer's therapeutics
por: Kantarci, Kejal
Publicado: (2022)

Unmasking the benefits of donepezil via psychometrically precise identification of mild cognitive impairment: A secondary analysis of the ADCS vitamin E and donepezil in MCI study
por: Edmonds, Emily C., et al.
Publicado: (2017)

Cortical Networks Underpinning Compensation of Verbal Fluency in Normal Aging
por: Gonzalez-Burgos, Lissett, et al.
Publicado: (2021)

Broader Considerations of Higher Doses of Donepezil in the Treatment of Mild, Moderate, and Severe Alzheimer's Disease
por: Berk, Camryn, et al.
Publicado: (2012)

Cilostazol Add-On Therapy in Patients with Mild Dementia Receiving Donepezil: A Retrospective Study
por: Ihara, Masafumi, et al.
Publicado: (2014)

Antidepressant, anxiolytic and procognitive effects of rivastigmine and donepezil in the chronic mild stress model in rats
por: Papp, Mariusz, et al.
Publicado: (2016)

Efficacy of Galantamine on Cognition in Mild-to-Moderate Alzheimer's Dementia after Failure to Respond to Donepezil
por: Hwang, Tae-Young, et al.
Publicado: (2016)

Comparison of Steady-State Pharmacokinetics of Donepezil Transdermal Delivery System with Oral Donepezil
por: Tariot, Pierre N., et al.
Publicado: (2022)

Imaging Biomarkers for Neurodegeneration in Presymptomatic Familial Frontotemporal Lobar Degeneration
por: Chen, Qin, et al.
Publicado: (2020)

Safety and efficacy of donepezil hydrochloride in patients with mild to moderate Alzheimer's disease: Findings of an observational study
por: Mehta, Suyog, et al.
Publicado: (2012)

Intepirdine as adjunctive therapy to donepezil for mild‐to‐moderate Alzheimer's disease: A randomized, placebo‐controlled, phase 3 clinical trial (MINDSET)
por: Lang, Frederick M., et al.
Publicado: (2021)

CSF tau and β-amyloid as biomarkers for mild cognitive impairment
por: Hampel, Harald, et al.
Publicado: (2004)

Functional Connectivity and Compensation of Phonemic Fluency in Aging
por: Mohanty, Rosaleena, et al.
Publicado: (2021)

Aptamers as biomarkers for neurological disorders. Proof of concept in transgenic mice
por: Lecocq, Soizic, et al.
Publicado: (2018)

Donepezil Beyond Alzheimer's Disease? A Narrative Review of Therapeutic Potentials of Donepezil in Different Diseases
por: Pooladgar, Parham, et al.
Publicado: (2022)

Magnetic resonance spectroscopy in Alzheimer’s disease
por: Graff-Radford, Jonathan, et al.
Publicado: (2013)

Have we learnt all we need to know from genetic studies - is genetics over in Alzheimer's disease?
por: Hampel, Harald, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_g2m9vjeeagc00i02rockmrjns4